The American College of Physicians (ACP) has published a position paper calling for sweeping reforms to how the FDA regulates dietary supplements, arguing that the current system fails to protect consumers from unsafe and mislabeled products. The organization is pushing Congress to modernize the Dietary Supplement Health and Education Act (DSHEA) of 1994, which has governed supplement oversight for over three decades.

Why Are Doctors Concerned About Current Supplement Oversight?

The core problem is straightforward: dietary supplements are regulated as a subcategory of food, not drugs. This means manufacturers are generally not required to prove their products are safe or effective before selling them to consumers. Instead, the FDA relies on postmarket surveillance, catching problems only after supplements have already entered the market and potentially harmed people.

The scale of the issue is striking. Between 2004 and 2021, the FDA's Center for Food Safety and Applied Nutrition (CFSAN) received 79,071 reports of adverse events linked to dietary supplements. Meanwhile, as many as 100,000 supplement products are available on the market, and 57.6 percent of American adults reported using a dietary supplement within the previous 30 days. This widespread use combined with minimal premarket oversight creates what the ACP describes as a significant public health risk.

"The reliance on postmarket surveillance in the regulation of dietary supplements is inadequate to protect public health and safety," the organization stated in its position paper.

American College of Physicians, Annals of Internal Medicine

What Changes Are Doctors Recommending?

The ACP has outlined a comprehensive set of reforms aimed at bringing supplement regulation more in line with how prescription drugs are overseen. These recommendations span both regulatory changes and broader systemic improvements.

• Premarket Review: All dietary supplements, including products already on the market, should undergo evidence-based review, registration, and approval by the FDA before being sold to consumers.
• Quality Standards: Supplements should be required to meet quality standards established by the U.S. Pharmacopeia (USP), an independent organization that sets standards for medicines and supplements.
• Stronger Recall Authority: The FDA should have expanded mandatory recall powers for adulterated or mislabeled products, allowing faster removal of dangerous items from store shelves.
• Enhanced Surveillance: The FDA's postmarket surveillance authority should be strengthened, and adverse event reporting systems should be improved to catch problems more quickly.
• Better Funding: Both the FDA and the Federal Trade Commission (FTC) need additional resources to oversee supplement manufacturing, labeling, and marketing claims.

Beyond regulatory changes, the ACP also recommended creating a publicly accessible national database of dietary supplements so consumers and healthcare providers can access reliable information. The organization called for integrating supplement interaction alerts into electronic health records, similar to how doctors are warned about drug interactions when prescribing medications. Improved education for both clinicians and patients, along with increased funding for research on supplement safety and interactions with prescription drugs, round out the recommendations.

How Can Consumers Protect Themselves Right Now?

While waiting for regulatory changes, there are steps you can take to make safer supplement choices.

• Talk to Your Doctor: Before starting any supplement, discuss it with your healthcare provider to check for potential interactions with medications you're taking or health conditions you have.
• Look for Third-Party Verification: Choose supplements that have been tested and verified by organizations like the U.S. Pharmacopeia (USP) or NSF International, which conduct independent quality checks.
• Report Problems: If you experience any adverse effects from a supplement, report it to the FDA's MedWatch program or tell your healthcare provider, helping regulators identify unsafe products.
• Check Labels Carefully: Read ingredient lists and dosage information thoroughly, and be skeptical of exaggerated health claims that sound too good to be true.

The ACP's position paper represents a significant moment in the ongoing debate over supplement regulation. For decades, the supplement industry has operated under a relatively light regulatory touch compared to pharmaceuticals. The organization's call for modernization reflects growing frustration among physicians who see patients harmed by contaminated, mislabeled, or ineffective products that should never have reached the market in the first place. Whether Congress will act on these recommendations remains to be seen, but the pressure from major medical organizations suggests that change may be coming.